SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based gene therapies, announced ...

Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases, today announced it has mapped CRISPR-addressable regions across 25 out of 25 viral ...

A lab course at UB is giving undergraduate biology students hands-on experience with CRISPR, a revolutionary gene-editing technique. CRISPR allows scientists to disable or alter specific sections of ...

Originally developed for gene editing, CRISPR-Cas systems have now become powerful molecular diagnostic tools. However, their widespread adoption in diagnostics has relied heavily on traditional ...

In 2020, Jennifer Doudna won the Nobel Prize in chemistry for her work on the CRISPR-Cas9 gene-editing technology that allows ...

Add Yahoo as a preferred source to see more of our stories on Google. spindle-shape muscle cells shown depicted in bright green and blue against a black background Scientists have transformed cancer ...

Seek Labs’ Programmable Target Ablation Platform (PTAP), uses CRISPR-based constructs to selectively disrupt viral DNA or RNA at conserved genomic sites. Those targets are identified and continuously ...

Researchers from Skoltech—a VEB.RF group institution—and their colleagues from the U.S. and China have explained how the ...

Researchers at Columbia University’s Sadelain lab and University Hospital Tubingen used CRISPR gene editing to knock out the ...

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a private TechBio company building a programmable disease response platform to detect, protect, and counter disease threats, has been awarded $2 million ...